ID   TP4A2_HUMAN             Reviewed;         167 AA.
AC   Q12974; A8K9I8; B4DM39; D3DPP0; E9PGJ6; O00649; Q15197; Q15259;
AC   Q15260; Q15261; R4GN50;
DT   05-JUL-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   15-MAR-2017, entry version 159.
DE   RecName: Full=Protein tyrosine phosphatase type IVA 2;
DE            EC=3.1.3.48;
DE   AltName: Full=HU-PP-1;
DE   AltName: Full=OV-1;
DE   AltName: Full=PTP(CAAXII);
DE   AltName: Full=Protein-tyrosine phosphatase 4a2;
DE   AltName: Full=Protein-tyrosine phosphatase of regenerating liver 2;
DE            Short=PRL-2;
DE   Flags: Precursor;
GN   Name=PTP4A2; Synonyms=PRL2, PTPCAAX2; ORFNames=BM-008;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Ovary;
RX   PubMed=8529999; DOI=10.1007/BF00197407;
RA   Montagna M., Serova O., Sylla B.S., Feunteun J., Lenoir G.M.;
RT   "A 100-kb physical and transcriptional map around the EDH17B2 gene:
RT   identification of three novel genes and a pseudogene of a human
RT   homologue of the rat PRL-1 tyrosine phosphatase.";
RL   Hum. Genet. 96:532-538(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), ISOPRENYLATION AT CYS-164, AND
RP   ENZYME REGULATION.
RC   TISSUE=Mammary carcinoma;
RX   PubMed=9018080; DOI=10.1016/S0304-3835(96)04459-X;
RA   Cates C.A., Michael R.L., Stayrook K.R., Harvey K.A., Burke Y.D.,
RA   Randall S.K., Crowell P.L., Crowell D.N.;
RT   "Prenylation of oncogenic human PTP(CAAX) protein tyrosine
RT   phosphatases.";
RL   Cancer Lett. 110:49-55(1996).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORMS 1 AND 2), AND TISSUE
RP   SPECIFICITY.
RC   TISSUE=Ovary, and Placenta;
RX   PubMed=8661118; DOI=10.1006/geno.1996.0336;
RA   Zhao Z., Lee C.-C., Monckton D.G., Yazdani A., Coolbaugh M.I., Li X.,
RA   Bailey J., Shen Y., Caskey C.T.;
RT   "Characterization and genomic mapping of genes and pseudogenes of a
RT   new human protein tyrosine phosphatase.";
RL   Genomics 35:172-181(1996).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Bone marrow;
RA   Zhao M., Song H., Li N., Peng Y., Han Z., Chen Z.;
RT   "A novel gene expressed in human bone marrow.";
RL   Submitted (NOV-1999) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 3).
RC   TISSUE=Brain, and Thymus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 14-167 (ISOFORM 1).
RC   TISSUE=Mammary gland;
RX   PubMed=7490091; DOI=10.1006/geno.1995.1185;
RA   Rommens J.M., Durocher F., McArthur J., Tonin P., Leblanc J.-F.,
RA   Allen T., Samson C., Ferri L., Narod S., Morgan K., Simard J.;
RT   "Generation of a transcription map at the HSD17B locus centromeric to
RT   BRCA1 at 17q21.";
RL   Genomics 28:530-542(1995).
RN   [10]
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=10940933;
RX   DOI=10.1002/1521-4141(2000)30:8<2412::AID-IMMU2412>3.0.CO;2-J;
RA   Gjoerloff-Wingren A., Saxena M., Han S., Wang X., Alonso A.,
RA   Renedo M., Oh P., Williams S., Schnitzer J., Mustelin T.;
RT   "Subcellular localization of intracellular protein tyrosine
RT   phosphatases in T cells.";
RL   Eur. J. Immunol. 30:2412-2421(2000).
RN   [11]
RP   INTERACTION WITH RABGGTB, ISOPRENYLATION AT CYS-164, SUBCELLULAR
RP   LOCATION, AND MUTAGENESIS OF 164-CYS--GLN-167 AND CYS-165.
RX   PubMed=11447212; DOI=10.1074/jbc.M010400200;
RA   Si X., Zeng Q., Ng C.H., Hong W., Pallen C.J.;
RT   "Interaction of farnesylated PRL-2, a protein-tyrosine phosphatase,
RT   with the beta-subunit of geranylgeranyltransferase II.";
RL   J. Biol. Chem. 276:32875-32882(2001).
RN   [12]
RP   TISSUE SPECIFICITY.
RX   PubMed=11734337; DOI=10.1016/S0304-3835(01)00703-0;
RA   Wang Q., Holmes D.I.R., Powell S.M., Lu Q.L., Waxman J.;
RT   "Analysis of stromal-epithelial interactions in prostate cancer
RT   identifies PTPCAAX2 as a potential oncogene.";
RL   Cancer Lett. 175:63-69(2002).
RN   [13]
RP   SUBCELLULAR LOCATION, AND LACK OF INTERACTION WITH TUBULIN.
RX   PubMed=12235145; DOI=10.1074/jbc.M206407200;
RA   Wang J., Kirby C.E., Herbst R.;
RT   "The tyrosine phosphatase PRL-1 localizes to the endoplasmic reticulum
RT   and the mitotic spindle and is required for normal mitosis.";
RL   J. Biol. Chem. 277:46659-46668(2002).
RN   [14]
RP   ENZYME REGULATION.
RX   PubMed=12516958;
RA   Pathak M.K., Dhawan D., Lindner D.J., Borden E.C., Farver C., Yi T.;
RT   "Pentamidine is an inhibitor of PRL phosphatases with anticancer
RT   activity.";
RL   Mol. Cancer Ther. 1:1255-1264(2002).
RN   [15]
RP   FUNCTION.
RX   PubMed=14643450; DOI=10.1016/S0304-3835(03)00517-2;
RA   Werner S.R., Lee P.A., DeCamp M.W., Crowell D.N., Randall S.K.,
RA   Crowell P.L.;
RT   "Enhanced cell cycle progression and down regulation of p21(Cip1/Waf1)
RT   by PRL tyrosine phosphatases.";
RL   Cancer Lett. 202:201-211(2003).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
CC   -!- FUNCTION: Protein tyrosine phosphatase which stimulates
CC       progression from G1 into S phase during mitosis. Promotes tumors.
CC       Inhibits geranylgeranyl transferase type II activity by blocking
CC       the association between RABGGTA and RABGGTB.
CC       {ECO:0000269|PubMed:14643450}.
CC   -!- CATALYTIC ACTIVITY: Protein tyrosine phosphate + H(2)O = protein
CC       tyrosine + phosphate.
CC   -!- ENZYME REGULATION: Inhibited by sodium orthovanadate and
CC       pentamidine. {ECO:0000269|PubMed:12516958,
CC       ECO:0000269|PubMed:9018080}.
CC   -!- SUBUNIT: In contrast to PTP4A1 and PTP4A3, does not interact with
CC       tubulin. Interacts with RABGGTB. {ECO:0000269|PubMed:11447212}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane. Early endosome. Cytoplasm.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1; Synonyms=Ptp-IV1a, Ptp-IV1b;
CC         IsoId=Q12974-1; Sequence=Displayed;
CC       Name=2; Synonyms=PTP4Ar;
CC         IsoId=Q12974-2; Sequence=VSP_014404, VSP_014405;
CC       Name=3;
CC         IsoId=Q12974-3; Sequence=VSP_044813;
CC         Note=No experimental confirmation available.;
CC       Name=4;
CC         IsoId=Q12974-4; Sequence=VSP_055056;
CC         Note=No experimental confirmation available. Gene prediction
CC         based on EST data.;
CC   -!- TISSUE SPECIFICITY: Ubiquitously expressed, with highest levels in
CC       skeletal muscle, heart and thymus. Overexpressed in prostate tumor
CC       tissue. {ECO:0000269|PubMed:10940933, ECO:0000269|PubMed:11734337,
CC       ECO:0000269|PubMed:8661118}.
CC   -!- PTM: Farnesylated. Farnesylation is required for membrane
CC       targeting and for interaction with RABGGTB. Unfarnesylated forms
CC       are redirected to the nucleus and cytosol.
CC   -!- MISCELLANEOUS: A processed pseudogene with 96% sequence identity
CC       was found in the BRCA1 (113705) region of 17q21.
CC   -!- SIMILARITY: Belongs to the protein-tyrosine phosphatase family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U14603; AAA90979.1; -; mRNA.
DR   EMBL; U48297; AAB40598.1; -; mRNA.
DR   EMBL; L48722; AAB42169.1; -; Genomic_DNA.
DR   EMBL; L48723; AAB42170.1; -; Genomic_DNA.
DR   EMBL; L48937; AAB39331.1; -; Genomic_DNA.
DR   EMBL; AF208850; AAF64264.1; -; mRNA.
DR   EMBL; AK292703; BAF85392.1; -; mRNA.
DR   EMBL; AK297280; BAG59751.1; -; mRNA.
DR   EMBL; AL136115; CAI21726.1; -; Genomic_DNA.
DR   EMBL; CH471059; EAX07578.1; -; Genomic_DNA.
DR   EMBL; CH471059; EAX07579.1; -; Genomic_DNA.
DR   EMBL; CH471059; EAX07582.1; -; Genomic_DNA.
DR   EMBL; CH471059; EAX07583.1; -; Genomic_DNA.
DR   EMBL; BC070182; AAH70182.1; -; mRNA.
DR   EMBL; L39000; AAB59575.1; -; mRNA.
DR   CCDS; CCDS348.1; -. [Q12974-1]
DR   CCDS; CCDS53292.1; -. [Q12974-3]
DR   CCDS; CCDS59193.1; -. [Q12974-4]
DR   PIR; I68523; I68523.
DR   RefSeq; NP_001182029.1; NM_001195100.1. [Q12974-4]
DR   RefSeq; NP_001182030.1; NM_001195101.1. [Q12974-3]
DR   RefSeq; NP_536316.1; NM_080391.3. [Q12974-1]
DR   RefSeq; XP_005271288.1; XM_005271231.3. [Q12974-4]
DR   RefSeq; XP_005271289.1; XM_005271232.3. [Q12974-3]
DR   RefSeq; XP_016857890.1; XM_017002401.1. [Q12974-3]
DR   UniGene; Hs.470477; -.
DR   UniGene; Hs.713025; -.
DR   PDB; 5K22; X-ray; 3.00 A; A=1-163.
DR   PDB; 5K23; X-ray; 2.96 A; A=1-167.
DR   PDB; 5K25; X-ray; 3.05 A; A=1-167.
DR   PDBsum; 5K22; -.
DR   PDBsum; 5K23; -.
DR   PDBsum; 5K25; -.
DR   ProteinModelPortal; Q12974; -.
DR   SMR; Q12974; -.
DR   BioGrid; 113747; 20.
DR   IntAct; Q12974; 3.
DR   MINT; MINT-2806089; -.
DR   STRING; 9606.ENSP00000344909; -.
DR   BindingDB; Q12974; -.
DR   ChEMBL; CHEMBL1075105; -.
DR   DEPOD; Q12974; -.
DR   iPTMnet; Q12974; -.
DR   PhosphoSitePlus; Q12974; -.
DR   BioMuta; PTP4A2; -.
DR   DMDM; 68566159; -.
DR   EPD; Q12974; -.
DR   MaxQB; Q12974; -.
DR   PaxDb; Q12974; -.
DR   PeptideAtlas; Q12974; -.
DR   PRIDE; Q12974; -.
DR   DNASU; 8073; -.
DR   Ensembl; ENST00000457805; ENSP00000409260; ENSG00000184007. [Q12974-3]
DR   Ensembl; ENST00000602683; ENSP00000473490; ENSG00000184007. [Q12974-4]
DR   Ensembl; ENST00000602725; ENSP00000473259; ENSG00000184007. [Q12974-1]
DR   GeneID; 8073; -.
DR   KEGG; hsa:8073; -.
DR   UCSC; uc001btx.3; human. [Q12974-1]
DR   CTD; 8073; -.
DR   DisGeNET; 8073; -.
DR   GeneCards; PTP4A2; -.
DR   HGNC; HGNC:9635; PTP4A2.
DR   HPA; CAB011204; -.
DR   HPA; HPA003281; -.
DR   MIM; 601584; gene.
DR   neXtProt; NX_Q12974; -.
DR   OpenTargets; ENSG00000184007; -.
DR   PharmGKB; PA33978; -.
DR   eggNOG; KOG2836; Eukaryota.
DR   eggNOG; ENOG4111I7J; LUCA.
DR   GeneTree; ENSGT00390000009788; -.
DR   HOGENOM; HOG000231265; -.
DR   HOVERGEN; HBG071295; -.
DR   InParanoid; Q12974; -.
DR   KO; K18041; -.
DR   OMA; APIEKEG; -.
DR   OrthoDB; EOG091G0MYM; -.
DR   PhylomeDB; Q12974; -.
DR   TreeFam; TF313384; -.
DR   Reactome; R-HSA-8873719; RAB geranylgeranylation.
DR   SIGNOR; Q12974; -.
DR   GeneWiki; PTP4A2; -.
DR   GenomeRNAi; 8073; -.
DR   PRO; PR:Q12974; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000184007; -.
DR   CleanEx; HS_PTP4A2; -.
DR   ExpressionAtlas; Q12974; baseline and differential.
DR   Genevisible; Q12974; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005769; C:early endosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0004727; F:prenylated protein tyrosine phosphatase activity; TAS:ProtInc.
DR   Gene3D; 3.90.190.10; -; 1.
DR   InterPro; IPR029021; Prot-tyrosine_phosphatase-like.
DR   InterPro; IPR000242; PTPase_domain.
DR   InterPro; IPR003595; Tyr_Pase_cat.
DR   InterPro; IPR000387; TYR_PHOSPHATASE_dom.
DR   Pfam; PF00102; Y_phosphatase; 1.
DR   SMART; SM00404; PTPc_motif; 1.
DR   SUPFAM; SSF52799; SSF52799; 1.
DR   PROSITE; PS50056; TYR_PHOSPHATASE_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell membrane; Complete proteome;
KW   Cytoplasm; Disulfide bond; Endosome; Hydrolase; Lipoprotein; Membrane;
KW   Methylation; Prenylation; Protein phosphatase; Reference proteome.
FT   CHAIN         1    164       Protein tyrosine phosphatase type IVA 2.
FT                                /FTId=PRO_0000094785.
FT   PROPEP      165    167       Removed in mature form. {ECO:0000305}.
FT                                /FTId=PRO_0000396731.
FT   DOMAIN       79    145       Tyrosine-protein phosphatase.
FT   REGION      102    107       Phosphate binding. {ECO:0000250}.
FT   ACT_SITE     69     69       Proton donor. {ECO:0000250}.
FT   ACT_SITE    101    101       Phosphocysteine intermediate.
FT   BINDING     107    107       Substrate. {ECO:0000250}.
FT   MOD_RES     164    164       Cysteine methyl ester. {ECO:0000305}.
FT   LIPID       164    164       S-farnesyl cysteine.
FT                                {ECO:0000269|PubMed:11447212,
FT                                ECO:0000269|PubMed:9018080}.
FT   DISULFID     46    101       {ECO:0000250}.
FT   VAR_SEQ      33     63       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_044813.
FT   VAR_SEQ      64     82       DWPFDDGAPPPNQIVDDWL -> KKKGSVQFQTAALFGEIP
FT                                T (in isoform 2). {ECO:0000305}.
FT                                /FTId=VSP_014404.
FT   VAR_SEQ      83    167       Missing (in isoform 2). {ECO:0000305}.
FT                                /FTId=VSP_014405.
FT   VAR_SEQ     108    132       Missing (in isoform 4). {ECO:0000305}.
FT                                /FTId=VSP_055056.
FT   MUTAGEN     164    167       Missing: Locates in the nucleus and
FT                                cytosol. No interaction with RABGGTB.
FT                                {ECO:0000269|PubMed:11447212}.
FT   MUTAGEN     165    165       C->S: No effect on interaction with
FT                                RABGGTB. {ECO:0000269|PubMed:11447212}.
FT   CONFLICT     13     13       N -> D (in Ref. 3; AAB39331).
FT                                {ECO:0000305}.
FT   CONFLICT     53     53       A -> D (in Ref. 9; AAB59575).
FT                                {ECO:0000305}.
FT   CONFLICT    102    102       V -> F (in Ref. 5; BAG59751).
FT                                {ECO:0000305}.
FT   STRAND        7     10       {ECO:0000244|PDB:5K23}.
FT   STRAND       15     19       {ECO:0000244|PDB:5K23}.
FT   TURN         24     26       {ECO:0000244|PDB:5K23}.
FT   HELIX        27     36       {ECO:0000244|PDB:5K23}.
FT   STRAND       39     44       {ECO:0000244|PDB:5K23}.
FT   HELIX        53     56       {ECO:0000244|PDB:5K23}.
FT   TURN         57     59       {ECO:0000244|PDB:5K23}.
FT   STRAND       61     64       {ECO:0000244|PDB:5K23}.
FT   HELIX        75     91       {ECO:0000244|PDB:5K23}.
FT   STRAND       96    100       {ECO:0000244|PDB:5K23}.
FT   STRAND      102    106       {ECO:0000244|PDB:5K23}.
FT   HELIX       107    118       {ECO:0000244|PDB:5K23}.
FT   HELIX       123    133       {ECO:0000244|PDB:5K23}.
FT   STRAND      134    136       {ECO:0000244|PDB:5K25}.
FT   HELIX       140    148       {ECO:0000244|PDB:5K23}.
SQ   SEQUENCE   167 AA;  19127 MW;  E97B88BF87B87943 CRC64;
     MNRPAPVEIS YENMRFLITH NPTNATLNKF TEELKKYGVT TLVRVCDATY DKAPVEKEGI
     HVLDWPFDDG APPPNQIVDD WLNLLKTKFR EEPGCCVAVH CVAGLGRAPV LVALALIECG
     MKYEDAVQFI RQKRRGAFNS KQLLYLEKYR PKMRLRFRDT NGHCCVQ
//
